NASDAQ: LRMRRUSSELL2000
Larimar Therapeutics, Inc.
Healthcare · Biotechnology · Headquartered in Bala Cynwyd, US
Price
Loading chart…
Overview
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Larimar Therapeutics, Inc., its business model, key products, and controversies.